Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol

acute tumor lysis syndrome and treatment

acute tumor lysis syndrome and treatment response in patients treated for refractory chronic lymphocytic leukemia with short-course, high-dose cytosine arabinoside, cisplatin, and etoposide

✍ Robert D. McCroskey; Deane F. Mosher; Cory D. Spencer; Edward Prendergast; Walte 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

Acute tumor lysis syndrome resulting from rapid neoplastic cell lysis after chemotherapy is an unusual event, generally seen in histologically aggressive lymphatic tumors. The authors saw four patients who developed acute tumor lysis syndrome when treated for advanced-stage, refractory chronic lymph